+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Intravenous magnesium for chronic complex regional pain syndrome type 1 (CRPS-1)

Intravenous magnesium for chronic complex regional pain syndrome type 1 (CRPS-1)

Pain Medicine 14(9): 1388-1399

To assess the effects of intravenous administration of magnesium on complex regional pain syndrome type 1 (CRPS-1), a randomized double-blind placebo-controlled trial was performed. Fifty-six patients with CRPS-1 (International Association for the Study of Pain Orlando criteria) received MgSO(4) 70 mg/kg or placebo (NaCl 0.9%) in 4 hours over 5 consecutive days. Pain (BOX-11 and McGill), the level of impairment (Impairment level Sum Score [ISS]), functional limitations (Radboud Skills Questionnaire, Walking Skills Questionnaire/questionnaire rising and sitting down), participation (Impact on Participation and Autonomy [IPA]), and quality of life (Short Form-36, EuroQol, IPA) were evaluated at baseline and at 1, 3, 6, and 12 weeks. No significant differences were found between MgSO(4) and placebo on the BOX-11 and ISS at different time points during the trial on intention-to-treat and per-protocol analysis. A significant improvement on the BOX-11 was found after the first week of the trial in both groups (mean 0.7; standard deviation 1.1). For the MgSO(4) group, a clinically relevant and statistically significant improvement on the ISS at 1 week (median 5, interquartile range [IQR] -1 to 8) and a significant improvement on the McGill up to 6 weeks (median 2 words, IQR 0-4.5) were found compared with baseline, which were not found in the placebo group. Significant improvement in perceived job participation was found for the MgSO(4) group at 12 weeks (median improvement 1.44-1.17; P = 0.01). ISS improved significantly more in patients with a low Hospital Anxiety and Depression Scale (HADS) score (≤10) in the MgSO(4) group (mean 4.4 vs mean -3.1; P = 0.02). Administration of the physiological competitive N-methyl-D-aspartate receptor antagonist magnesium in chronic CRPS provides insufficient benefit over placebo. Future research should focus on patients with acute CRPS and early signs and symptoms of central sensitization.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 037261109

Download citation: RISBibTeXText

PMID: 23889940

DOI: 10.1111/pme.12211

Related references

Intravenous magnesium for complex regional pain syndrome type 1 (CRPS 1) patients: a pilot study. Pain Medicine 10(5): 930-940, 2009

Enhanced pain and autonomic responses to ambiguous visual stimuli in chronic Complex Regional Pain Syndrome (CRPS) type I. European Journal of Pain 16(2): 182-195, 2012

Complex Regional Pain Syndrome (CRPS): High risk of CRPS after trauma in another limb in patients who already have CRPS in one hand or foot: Lasting changes in neural pain modulating systems?. Scandinavian Journal of Pain 14: 82-83, 2017

Proton magnetic resonance spectroscopy of the thalamus in chronic complex regional pain syndrome (CRPS) type-1 patients. Pain Clinic 14(4): 347-351, 2002

Complex regional pain syndrome (CRPS/RSD) and neuropathic pain: role of intravenous bisphosphonates as analgesics. Thescientificworldjournal 8: 229-236, 2008

Intravenous magnesium sulphate for the treatment of pain in Complex Regional Pain Syndrome type 1 (CRPS1): A pilot study. European Journal of Anaesthesiology 25(Sup 44): 211-212, 2008

Chronic post-ischemia pain (CPIP): a novel animal model of complex regional pain syndrome-type I (CRPS-I; reflex sympathetic dystrophy) produced by prolonged hindpaw ischemia and reperfusion in the rat. Pain 112(1-2): 94-105, 2004

Complex regional pain syndrome (CRPS)--is severe pain a good indicator for CRPS?. Zeitschrift für Orthopadie und Unfallchirurgie 152(1): 12, 2015

Complex regional pain syndrome type 1 (CRPS 1). Praxis 100(4): 191-8; Quiz 199-200, 2011

Reflex sympathetic dystrophy syndrome (RSDS), complex regional pain syndrome-type 1 (CRPS 1), neuropathic pain: an equine perspective. Journal of equine veterinary science 16(11): 463-468, 1996

Pathophysiology of complex regional pain syndrome (CRPS) type 1. La Tunisie Medicale 90(4): 278-281, 2012

Sex differences in complex regional pain syndrome type I (CRPS-I) in mice. Journal of Pain Research 10: 1811-1819, 2017

Complex regional pain syndrome type I (CRPS type I/"RSD") -- an overview. Zentralblatt für Chirurgie 131(3): W40-8; Quiz W49-50, 2006

The Treatment of the Complex Regional Pain Syndrome (CRPS 1 and CRPS 2) of the Upper Limb with Repeated Local Anaesthesia to the Stellate Ganglion.. Praxis 98(5): 247-257, 2016

Complex regional pain syndrome type I (CRPS I). Pathophysiology, diagnostics, and therapy. Der Orthopade 32(5): 418-431, 2003